Additive and Antagonistic Effects Among Combination of Agonists of Peroxisome Proliferator-Activated Receptor gamma (PPARg) on Transcriptional Activity

Journal Title: Diabetes Research – Open Journal - Year 2015, Vol 1, Issue 2

Abstract

Objective: The Angiotensin-II receptor blocker telmisartan and sulfonylurea glimepiride may have clinical usefulness as partial agonists of PPARg. We investigated additive and antagonistic effects among combinations of telmisartan, glimepiride, and the Thiazolidinedione (TZD) selective PPARg agonist pioglitazone on transcriptional activity of PPARg. Materials/Methods: The receptors of pCMX-PPARg and pCMX-RXR, and PPRE-Luc reporter gene were transfected into CV1 cells, and treated with following agents, and luciferace assay was performed. Moreover, mammalian two-hybrid assay was done using GAL4 responsive reporter tk-MH100(UAS)×4-Luc and the chimeric receptor GAL4-PPARg. Results: Telmisartan increased transactivation of PPARg dose dependently. Activation by telmisartan 10 µM was 58.8% of that by pioglitazone 10 µM. Glimepiride also increased transactivation of PPARg dose dependently. Activation by glimepiride 10 µM was 49.8% of that by pioglitazone 10 µM. Addition of telmisartan 5 µM significantly enhanced transactivation by glimepiride 10 and 50 µM. Moreover, addition of pioglitazone 0.5 µM significantly enhanced transactivation by glimepiride 10 and 50 µM. Mammalian two-hybrid assay showed additive effect between glimepiride and telmisartan on binding of SRC-1 to PPARg. On the other hand, addition of glimepiride 10 and 50 µM reduced transactivation by pioglitazone 5 µM to 74% and 70%, respectively. Conclusion: Partial agonists of PPARg additively enhanced transactivation by other agonists, whereas high concentration of partial agonists reduced transactivation by full agonist antagonistically.

Authors and Affiliations

Daisuke Tsuriya

Keywords

Related Articles

Intestinal Parasites in Diabetes Mellitus Patients in the Limbe and Buea Municipalities, Cameroon

Background: Intestinal parasites are an important cause of morbidity and mortality and a public health problem especially in tropical developing countries including Cameroon. The two main types of intestinal parasites ar...

Rapid Improvement of Blood Glucose Level after Prosthetic Mandibular Advancement in a Patient with Diabetes Mellitus and Obstructive Sleep Apnea

Introduction: Obstructive Sleep Apnea Syndrome (OSAS) is often associated with impaired glucose metabolism. However, the effects of Prosthetic Mandibular Advancement (PMA) on blood glucose levels and insulin resistance r...

Population-Based Strategy for Preventing Diabetes and its Complications

A recent report from the American College of Physicians (ACP) should cause a paradigm change for the treatment of diabetic patients.1 The main purpose of diabetes therapy is the prevention of complications.2 The endpoi...

Glycemic Variability: Clinical and Prognostic Significance

Minimizing development or progression of chronic diabetic micro and macro-vascular complications has been always the goal of glycemic control. In recent years, much attention has been focused on the possibility that glyc...

Effect of Low Carbohydrate Diet on Type 2 Diabetic Patients and Usefulness of M-Value

Background: Debate between the Calorie Restriction (CR) and Low-Carbohydrate Diet (LCD) has been continued for several years. We have started LCD therapy for diabetic patients since 1999, and experienced good response to...

Download PDF file
  • EP ID EP550007
  • DOI 10.17140/DROJ-1-105
  • Views 158
  • Downloads 0

How To Cite

Daisuke Tsuriya (2015). Additive and Antagonistic Effects Among Combination of Agonists of Peroxisome Proliferator-Activated Receptor gamma (PPARg) on Transcriptional Activity. Diabetes Research – Open Journal, 1(2), 27-33. https://europub.co.uk/articles/-A-550007